169 related articles for article (PubMed ID: 29378829)
1. Regulation of Cholesterol Sulfotransferase SULT2B1b by Hepatocyte Nuclear Factor 4α Constitutes a Negative Feedback Control of Hepatic Gluconeogenesis.
Bi Y; Shi X; Zhu J; Guan X; Garbacz WG; Huang Y; Gao L; Yan J; Xu M; Ren S; Ren S; Liu Y; Ma X; Li S; Xie W
Mol Cell Biol; 2018 Apr; 38(7):. PubMed ID: 29378829
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol sulfate and cholesterol sulfotransferase inhibit gluconeogenesis by targeting hepatocyte nuclear factor 4α.
Shi X; Cheng Q; Xu L; Yan J; Jiang M; He J; Xu M; Stefanovic-Racic M; Sipula I; O'Doherty RM; Ren S; Xie W
Mol Cell Biol; 2014 Feb; 34(3):485-97. PubMed ID: 24277929
[TBL] [Abstract][Full Text] [Related]
3. DAX-1 acts as a novel corepressor of orphan nuclear receptor HNF4alpha and negatively regulates gluconeogenic enzyme gene expression.
Nedumaran B; Hong S; Xie YB; Kim YH; Seo WY; Lee MW; Lee CH; Koo SH; Choi HS
J Biol Chem; 2009 Oct; 284(40):27511-23. PubMed ID: 19651776
[TBL] [Abstract][Full Text] [Related]
4. An Unexpected Role of Cholesterol Sulfotransferase and its Regulation in Sensitizing Mice to Acetaminophen-Induced Liver Injury.
An Y; Wang P; Xu P; Tung HC; Xie Y; Kirisci L; Xu M; Ren S; Tian X; Ma X; Xie W
Mol Pharmacol; 2019 Jun; 95(6):597-605. PubMed ID: 30944208
[TBL] [Abstract][Full Text] [Related]
5. The constitutive androstane receptor activator 4-[(4R,6R)-4,6-diphenyl-1,3-dioxan-2-yl]-N,N-dimethylaniline inhibits the gluconeogenic genes PEPCK and G6Pase through the suppression of HNF4α and FOXO1 transcriptional activity.
Yarushkin AA; Kachaylo EM; Pustylnyak VO
Br J Pharmacol; 2013 Apr; 168(8):1923-32. PubMed ID: 23231652
[TBL] [Abstract][Full Text] [Related]
6. Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis.
Rhee J; Inoue Y; Yoon JC; Puigserver P; Fan M; Gonzalez FJ; Spiegelman BM
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4012-7. PubMed ID: 12651943
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of hepatic HNF4alpha gene expression during hyperinsulinemia via SREBPs.
Xie X; Liao H; Dang H; Pang W; Guan Y; Wang X; Shyy JY; Zhu Y; Sladek FM
Mol Endocrinol; 2009 Apr; 23(4):434-43. PubMed ID: 19179483
[TBL] [Abstract][Full Text] [Related]
8. Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 Pathway.
Wei S; Zhang M; Yu Y; Lan X; Yao F; Yan X; Chen L; Hatch GM
PLoS One; 2016; 11(3):e0152097. PubMed ID: 27011261
[TBL] [Abstract][Full Text] [Related]
9. Oxysterol sulfation by cytosolic sulfotransferase suppresses liver X receptor/sterol regulatory element binding protein-1c signaling pathway and reduces serum and hepatic lipids in mouse models of nonalcoholic fatty liver disease.
Bai Q; Zhang X; Xu L; Kakiyama G; Heuman D; Sanyal A; Pandak WM; Yin L; Xie W; Ren S
Metabolism; 2012 Jun; 61(6):836-45. PubMed ID: 22225954
[TBL] [Abstract][Full Text] [Related]
10. Evodia alkaloids suppress gluconeogenesis and lipogenesis by activating the constitutive androstane receptor.
Yu L; Wang Z; Huang M; Li Y; Zeng K; Lei J; Hu H; Chen B; Lu J; Xie W; Zeng S
Biochim Biophys Acta; 2016 Sep; 1859(9):1100-1111. PubMed ID: 26455953
[TBL] [Abstract][Full Text] [Related]
11. High fat diet-induced oxidative stress blocks hepatocyte nuclear factor 4α and leads to hepatic steatosis in mice.
Yu D; Chen G; Pan M; Zhang J; He W; Liu Y; Nian X; Sheng L; Xu B
J Cell Physiol; 2018 Jun; 233(6):4770-4782. PubMed ID: 29150932
[TBL] [Abstract][Full Text] [Related]
12. Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice.
Zhang Y; Guan Q; Liu Y; Zhang Y; Chen Y; Chen J; Liu Y; Su Z
J Biol Chem; 2018 May; 293(20):7894-7904. PubMed ID: 29530977
[TBL] [Abstract][Full Text] [Related]
13. HNF4α contributes to glucose formation in aged rat hepatocytes.
Park EY; Lee CH; Lee EK; Kim JH; Cova A; Lee SK; Cho SC; Kwak CS; Song KY; Park SC; Jun HS; Kim KT
Exp Gerontol; 2013 Dec; 48(12):1518-25. PubMed ID: 24177414
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte Nuclear Factor 4α Prevents the Steatosis-to-NASH Progression by Regulating p53 and Bile Acid Signaling (in mice).
Xu Y; Zhu Y; Hu S; Xu Y; Stroup D; Pan X; Bawa FC; Chen S; Gopoju R; Yin L; Zhang Y
Hepatology; 2021 Jun; 73(6):2251-2265. PubMed ID: 33098092
[TBL] [Abstract][Full Text] [Related]
15. GSK3β regulates gluconeogenic gene expression through HNF4α and FOXO1.
Sakamaki J; Daitoku H; Kaneko Y; Hagiwara A; Ueno K; Fukamizu A
J Recept Signal Transduct Res; 2012 Apr; 32(2):96-101. PubMed ID: 22384829
[TBL] [Abstract][Full Text] [Related]
16. 18β-Glycyrrhetinic acid acts through hepatocyte nuclear factor 4 alpha to modulate lipid and carbohydrate metabolism.
Yang M; Zhang M; Liu Q; Xu T; Huang T; Yao D; Wong CW; Liu J; Guan M
Pharmacol Res; 2020 Jul; 157():104840. PubMed ID: 32353589
[TBL] [Abstract][Full Text] [Related]
17. HNF-4α regulated miR-122 contributes to development of gluconeogenesis and lipid metabolism disorders in Type 2 diabetic mice and in palmitate-treated HepG2 cells.
Wei S; Zhang M; Yu Y; Xue H; Lan X; Liu S; Hatch G; Chen L
Eur J Pharmacol; 2016 Nov; 791():254-263. PubMed ID: 27592052
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte nuclear factor 4α regulates the expression of the murine pyruvate carboxylase gene through the HNF4-specific binding motif in its proximal promoter.
Chavalit T; Rojvirat P; Muangsawat S; Jitrapakdee S
Biochim Biophys Acta; 2013 Oct; 1829(10):987-99. PubMed ID: 23665043
[TBL] [Abstract][Full Text] [Related]
19. Insulin-Inducible SMILE Inhibits Hepatic Gluconeogenesis.
Lee JM; Seo WY; Han HS; Oh KJ; Lee YS; Kim DK; Choi S; Choi BH; Harris RA; Lee CH; Koo SH; Choi HS
Diabetes; 2016 Jan; 65(1):62-73. PubMed ID: 26340929
[TBL] [Abstract][Full Text] [Related]
20. Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice.
De Souza CT; Frederico MJ; da Luz G; Cintra DE; Ropelle ER; Pauli JR; Velloso LA
J Physiol; 2010 Jun; 588(Pt 12):2239-53. PubMed ID: 20421289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
